Jiangsu Hualv Biological Technology Co.Ltd. Capital Reinvestment Ratio
Jiangsu Hualv Biological Technology Co.Ltd. capital reinvestment ratio. Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Capital Reinvestment Ratio of 0.36x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥345.31 Million) in capital expenditures (CN¥123.12 Million). Check Jiangsu Hualv Biological Technology Co.L cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Capital reinvestment ratio of Jiangsu Hualv Biological Technology Co.Ltd. from 2019 to 2025. This chart tracks Jiangsu Hualv Biological Technology Co.Ltd.'s Capital Reinvestment Ratio across 7 annual periods. Also explore how fast is Jiangsu Hualv Biological Technology Co.L growing its equity to track the company's year-over-year net asset growth rate.
Jiangsu Hualv Biological Technology Co.Ltd. Capital Reinvestment Ratio by Year (2019–2025)
Jiangsu Hualv Biological Technology Co.Ltd. capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Jiangsu Hualv Biological Technology Co.L cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | CN¥345.31 Million | CN¥123.12 Million | ▼ -81.7% |
| 2024 | 1.95x | CN¥137.80 Million | CN¥268.22 Million | ▲ +44.7% |
| 2023 | 1.34x | CN¥166.67 Million | CN¥224.15 Million | ▼ -40.7% |
| 2022 | 2.27x | CN¥179.84 Million | CN¥407.91 Million | ▼ -7.7% |
| 2021 | 2.46x | CN¥83.08 Million | CN¥204.09 Million | ▲ +156.1% |
| 2020 | 0.96x | CN¥199.09 Million | CN¥190.96 Million | ▲ +108.3% |
| 2019 | 0.46x | CN¥213.96 Million | CN¥98.54 Million | — |